Issue |
J Extra Corpor Technol
Volume 34, Number 3, September 2002
|
|
---|---|---|
Page(s) | 190 - 196 | |
DOI | https://doi.org/10.1051/ject/2002343190 | |
Published online | 11 August 2023 |
Expanding Perfusion Services Through Mobile Point-of-Care Coagulation Monitoring
Division of Clinical Perfusion Education, University of Nebraska Medical Center, School of Allied Health Professions, Omaha, Nebraska
* Address correspondence to: Ryan J. Kohtz, MPS, CCP, Division of Clinical Perfusion Education, University of Nebraska Medical Center, 985155 Nebraska Medical Center, Omaha, NE 68198-5155, E-mail: rkohtz@hotmail.com
Received:
22
March
2001
Accepted:
15
March
2002
Current trends in cardiac surgery have challenged perfusionists to seek diversification of services. Point-of-care coagulation (POCC) monitoring represents a desirable area of perfusion service expansion. The purpose of the study was to create a series of hemostatic conditions to assess the functionality of POCC monitors to identify specific coagulopathies with identifiable profiles for algorithm development.
Fresh (<4 h) bovine blood, anticoagulated with anticoagulant citrate dextrose, was adjusted to a hematocrit of 30.0 ± 2.0%. Hypofibrinogenemia (≤90 mg/dL), thrombocytopenia (≤70,000/ mm3), platelet dysfunction (850 µg/mL of nitroglycerin/mL of blood) and hyperfibrinolysis (0.40 units of urokinase/mL of blood) were created. Five POCC devices were used to evaluate activated clotting time, thrombin time, fibrinogen, platelet function, prothrombin time, activated partial thromboplastin time and thromboelastograph. Results are reported as percentage change from control for each test (abtract table). Each test performed showed specificity and sensitivity for certain coagulopathies, however variability amongst monitors was encountered. In conclusion, the development of a mobile cart incorporating POCC monitors with knowledge of specific coagulopathic conditions may expand perfusion service.
Summary of results for induced coagulopathesis.
Device | Hypofibrinogenemia | Thrombocytopenia | Platelet Dysfunction | Hyperfibrinolysis |
---|---|---|---|---|
TEG index | −146% p < .05 | −84% p < .05 | −415% p < .05 | −90% p < .05 |
ACT | 23% p < .05 | 4% p = NS | 89% p < .05 | 27% p < .05 |
Thrombin time | 16% p = NS | −4% p = NS | 19% p = NS | 20% p = NS |
Fibrinogen | –47% p < .05 | −19% p = <.05 | 12% p = NS | 5% p = NS |
Platelet function | No result | −43% p < NS | No result | −19% p = NS |
Key words: point of care / coagulation monitoring / algorithm
© 2002 AMSECT
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.